Global Pdx Models Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 142,396.93 Million |
 Market Size (Forecast Year) |
USD 500,362.17 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球患者来源异种移植 (PDX) 模型市场，按类型（小鼠模型、大鼠模型）、肿瘤类型（呼吸道肿瘤模型、泌尿系统肿瘤模型、胃肠道肿瘤模型、血液系统肿瘤模型、妇科肿瘤模型等）、应用（临床前药物开发和肿瘤学研究、生物标志物分析）、最终用户（合同研究组织、学术和研究机构、制药和生物技术公司）划分 – 行业趋势和预测至 2029 年
全球患者来源异种移植 (PDX) 模型市场分析和规模
众所周知，异种移植肿瘤模型保留了原始肿瘤特征，包括临床生物分子特征、肿瘤档案、异质组织学、恶性表型和基因型等。
- 对癌症研究的支持增加，推动了患者来源异种移植 (PDX) 模型市场的增长。2021 年全球患者来源异种移植 (PDX) 模型市场价值为 142,396.93 百万美元，预计到 2029 年将达到 500,362.17 百万美元，在 2022-2029 年预测期内的复合年增长率为 17.01%。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（小鼠模型、大鼠模型）、肿瘤类型（呼吸道肿瘤模型、泌尿系统肿瘤模型、胃肠道肿瘤模型、血液系统肿瘤模型、妇科肿瘤模型、其他）、应用（临床前药物开发和肿瘤学研究、生物标志物分析）、最终用户（合同研究组织、学术和研究机构、制药和生物技术公司） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
|
涵盖的市场参与者 |
Crown Bioscience Inc.（美国）、THE JACKSON LABORATORY（美国）、Champions Oncology, Inc.（美国）、Charles River Laboratories（美国）、无锡药明康德（中国）、Oncodesign（加拿大）、Aragen Bioscience（印度）、Biocytogen（美国）、Bioduro（美国）、Creative Animodel（美国）、Covance Inc.（美国）、EPO Berlin-Buch GmbH（德国）、EUROPDX.（比利时）、Explora BioLabs（美国）、Hera BioLabs（美国）、Horizon discovery Ltd.（英国）、Pharmatest Services（芬兰）、Urospehere SAS（塞浦路斯）、Xentech（法国）、Xenopat（法国）等 |
|
市场机会 |
|
Global Patient Derived Xenograft (PDX) Models Market Definition
Patient-derived xenografts (PDX) refer to the models of cancer where cells or tissues from a tumor of a patient that are implanted into humanized or immunedeficient mouse. These models are known to simulate human tumor biology that enables natural cancer progression. This provides translational research model in order to evaluate efficacy.
Patient Derived Xenograft (PDX) Models Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Demand for Personalized Medicine
The increase in demand for personalized medicine across the globe acts as one of the major factors driving the growth of patient derived xenograft (PDX) models market.
- Continuous Support for Cancer Research
The continuous support for cancer research from the public and private sectors in the form of funds and investments accelerate the market growth.
- Research and Development
The surge in the number of research and development activities to enhance the treatment options available further influence the market.
Opportunities
Furthermore, rise in demand for humanized PDX models extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, technological development will further expand the market.
Restraints/Challenges Global Patient Derived Xenograft (PDX) Models Market
On the other hand, high cost associated with the personalized PDX models and stringent guidelines for the use of animal models in cancer research are expected to obstruct market growth. Also, limitations of PDX models are projected to challenge the patient derived xenograft (PDX) models market in the forecast period of 2022-2029.
This patient derived xenograft (PDX) models market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on patient derived xenograft (PDX) models market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Patient Derived Xenograft (PDX) Models Market
Covid-19 had a negative impact on the patient derived xenograft (PDX) models market owing to the decline in the productivity in life science organizations during the pandemic. The reduction in pharma research and development deals in therapeutic areas, disruption of clinical trials and country-wise lockdowns also impacted the market. The most affected trials were associated with oncology, ID/anti-infectives, cardiovascular disease and respiratory disease. The market will regain its growth the impact of COVID-19 is expected to diminish during the post-pandemic scenario.
Recent Development
- Collagen Matrix, Inc., a global leader collagen-based, regenerative, xenograft-derived medical devices, and Linden Capital Partners (“Linden”) announced the acquisition of Sunstar’s Degradable Solutions division. It included GUIDOR branded line of resorbable synthetic medical implants. The purpose behind the acquisition is expanding the range of technologies offered to the customers.
Global Patient Derived Xenograft (PDX) Models Market Scope and Market Size
The patient derived xenograft (PDX) models market is segmented on the basis of type, tumor type, application, technique and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Mice Models
- Rat Models
On the basis of type, the global patient derived xenograft (PDX) models market is classified into mice models and rat models.
Tumor Type
- Gastrointestinal Tumor Models
- Lung Tumor Models
- Haematological Tumor Models
- Gynecological Tumor Models
- Respiratory Tumor Models
- Urological Tumor Models
- Others
On the basis of tumor type, the global patient derived xenograft (PDX) models market is classified into gastrointestinal tumor models, lung tumor models, haematological tumor models, gynecological tumor models, respiratory tumor models, urological tumor models and others.
Application
- Preclinical Drug Development
- Precision Medicine
- Co-Clinical Trials
- Basic Cancer Research
On the basis of application, the global patient derived xenograft (PDX) models market is classified into preclinical drug development, precision medicine, co-clinical trials, and basic cancer research.
Technique
- Heterotopic Implantation
- Orthotropic Implantation
On the basis of technique, the global patient derived xenograft (PDX) models market are segmented into heterotopic implantation and orthotropic implantation.
End User
- Academic and Research Organizations
- Contract Research Organizations
- Pharmaceutical and Biotechnological Companies
- Others
On the basis of end user, the global patient derived xenograft (PDX) models market is segmented into academic and research organizations, contract research organizations, pharmaceutical and biotechnological companies and others.
患者来源异种移植 (PDX) 模型市场区域分析/见解
对患者来源的异种移植 (PDX) 模型市场进行了分析，并按国家、类型、肿瘤类型、应用、技术和最终用户提供了市场规模洞察和趋势。
患者来源的异种移植 (PDX) 模型市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲的其他地区。
由于北美地区癌症和干细胞研究活动的增加，北美在患者来源异种移植 (PDX) 模型市场中占据主导地位。
由于该地区癌症发病率上升，预计亚太地区 (APAC) 在 2022 年至 2029 年的预测期内将出现显著增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
患者来源异种移植 (PDX) 模型市场还为您提供详细的市场分析，包括每个国家/地区资本设备医疗保健支出的增长、患者来源异种移植 (PDX) 模型市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对患者来源异种移植 (PDX) 模型市场的影响。数据涵盖 2010-2020 年的历史时期。
竞争格局和患者来源异种移植 (PDX) 模型市场份额分析
患者来源异种移植 (PDX) 模型市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对患者来源异种移植 (PDX) 模型市场的关注有关。
患者来源异种移植 (PDX) 模型市场的一些主要参与者包括：
- Crown Bioscience Inc.（美国）
- 杰克逊实验室（美国）
- Champions Oncology, Inc.（美国）
- Charles River Laboratories（美国）
- 无锡药明康德 (中国)
- Oncodesign（加拿大）
- Aragen Bioscience（印度）
- 百奥赛特 (美国)
- 保诺科技 (美国)
- 创意动画模型（美国）
- Covance Inc.（美国）
- EPO Berlin-Buch GmbH（德国）
- EUROPDX。（比利时）
- Explora BioLabs（美国）
- Hera BioLabs（美国）
- Horizon discovery Ltd.（英国）
- Pharmatest Services（芬兰）
- Urospehere SAS（塞浦路斯）
- Xentech (法国)
- Xenopat（法国）
研究方法：全球患者来源异种移植 (PDX) 模型市场
数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请咨询我们的行业专家 https://www.databridgemarketresearch.com/zh/speak-to-analyst/?dbmr=global-pdx-models-market
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
